Abstract
Association of alleles at the Taql A, Taql B, intron 6, Taql D, exon 7, exon 8, and promoter-141C sites of the D2 dopamine receptor gene with D2 dopamine receptor binding characteristics in the caudate nucleus of Caucasian alcoholic and nonalcoholic subjects was determined. For the Taql D, exon 7, exon 8, and promoter-141C sites there were no significant allelic differences in Bmax (number of binding sites) or Kd (binding affinity) of the D2 dopamine receptors. However, subjects having the minor alleles at the Taql A, Taql B, and intron 6 sites had significantly lower Bmax than subjects not having them. None of these three polymorphisms had any significant effect on Kd. Highly significant linkage disequilibria were observed among the Taql A, Taql B, and intron 6 polymorphic sites, but linkage disequilibria between these three sites and each of the Taql D, exon 7, exon 8, and promoter-141C sites were of lesser or of no significance. Taken together, these findings suggest that the Taql A, Taql B, and intron 6 polymorphisms, but not the Taql D, exon 7, exon 8, and promoter-141C polymorphisms, are in linkage disequilibrium with a functional allelic variant that affects D2 dopamine receptor expression.
Similar content being viewed by others
REFERENCES
Koob, Y. and LeMoal, M. 1997. Drug abuse: Hedonic homeostatic dysregulation. Science 278:52–58.
Tanda, G., Pontieri, F. E., and Di Chiara, G. 1997. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common μl opioid receptor mechanism. Science 276:2048–2050.
Blum, K., Noble, E. P., Sheridan, P. J., Montgomery, A., Ritchie, T., Jagadeeswaren, P., Nogami, H., Briggs, A. H., and Cohn, J. B. 1990. Allelic association of the human dopamine D2 receptor gene in alcoholism. J. Am. Med. Assoc. 263:2055-2060.
Amadéo, S., Abbar, M., Fourcade, M. L., Waksman, G., Leroux, M. G., Medec, A., Selin, M., Champiat, J.-C., Brethome, A., Leclair, Y., Castelnau, D., Venisse, J.-L., and Mallet, J. 1993. D2 dopamine receptor gene and alcoholism. J. Psychiatr. Res. 27:173-179.
Blum, K., Noble, E. P., Sheridan, P. J., Finley, O., Montgomery, A., Ritchie, T., Ozkaragoz, T., Fitch, R. J., Sadlack, F., Sheffield, D., Dahlmann, T., Halbardier, S., and Nogami, H. 1991. Association of the A1 allele of the human D2 dopamine receptor gene with severe alcoholism. Alcohol 8:409–416.
Comings, D. E., Comings, B. G., Muhleman, D., Dietz, G., Shahbahrami, B., Tast, D., Knell, E., Kocsis, P., Baumgarten, R., Kovacs, B. W., Levy, D. L., Smith, M., Borison, R. L., Evans, D. D., Klein, D. N., MacMurray, J., Tosk, J. F., Sverd, J., Gysin, R., and Flanagan, S. D. 1991. The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. J. Am. Med. Assoc. 266:1793–1800.
Hietala, J., Pohjalainen, T., Heikkila-Kallio, U., West, C., Salaspuro, M., and Syvälahti, E. 1997. Allelic association between D2 but not D1 dopamine receptor gene and alcoholism in Finland. Psychiat. Genet. 7:19–25.
Lawford, B. R., Young, R. M., Rowell, J. A., Gibson, J. N., Feeney, G. F. X., Ritchie, T. L., Syndulko, K., and Noble, E. P. 1997. Association of the D2 dopamine receptor A1 allele with alcoholism: Medical severity of alcoholism and type of controls. Biol. Psychiatry 41:386–393.
Neiswanger, K., Hill, S. Y., and Kaplan, B. B. 1995. Association and linkage studies of the Taql A allele of the dopamine D2 receptor gene in samples of female and male alcoholics. Am. J. Med. Genet. 60:267–271.
Noble, E. P., Syndulko, K., Fitch, R. J., Ritchie, T., Bohlman, M. C., Guth, P., Sheridan, P. J., Montegomery, A., Heinzmann, C., Sparkes, R. S., and Blum, K. 1994. D2 dopamine receptor Taql A alleles in medically ill alcoholic and nonalcoholic patients. Alcohol Alcohol. 29:729–744.
Ovchinnikov, I. V., Druzina, E., Ovchinnikova, O., Zagorovskaya, T., Nebrakova, T., Anokhina, I. P. 1999. Polymorphism of dopamine D2 and D4 receptor genes and Slavic-surnamed alcoholic patients. Addiction Biol. 4:399–404.
Parsian, A., Todd, R. D., Devor, E. J., O'Malley, K. L., Suarez, B. K., Reich, T., and Cloninger, C. R. 1991. Alcoholism and alleles of the human D2 receptor locus: Studies of association and linkage. Arch. Gen. Psychiatry 48:655–663.
Bolos, A. M., Dean, M., Lucase-Derse, S., Ramsburg, M., Brown, G. L., Goldman, D. 1990. Population and pedigree studies reveal a lack of association between dopamine D2 receptor gene and alcoholism. JAMA 264:3156–3160.
Cook, B. L., Wang, Z. W., Crowe, R. R., Hauser, R., and Freimer, M. 1992. Alcoholism and the D2 receptor gene. Alcohol. Clin. Exp. Res. 16:806–809.
Geijer, T., Neiman, J., Rydberg, U., Gyllander, A., Jöhnson, E., Sedvall, G., Valverius, P., and Terenius, L. 1994. Dopamine D2 receptor gene polymorphisms in Scandinavian chronic alcoholics. Eur. Arch. Psychiatry Clin. Neurosci. 244:26–32.
Gelernter, J., O'Malley, S., Risch, N., Kranzler, H. R., Krystal, J., Merikangas, K., Kennedy, J. F., and Kidd, K. K. 1991. No association between an allele of the D2 dopamine receptor gene (DRD2) and alcoholism. JAMA 266:1801–1807.
Goldman, D., Dean, M., Brown, G. L., Bolos, A. N., Tokola, R., Virkkunen, M., and Linnoila, M. 1992. D2 dopamine receptor genotype and cerebral spinal fluid homovanillic acid, 5-hydroxy-indoleacetic acid and 3-methoxy-4-hydroxyphenylglycol in alcoholics in Finland and the United States. Acta Psychiatr. Scand. 86:351–357.
Heintz, A., Sander, T., Harms, H., Finckh, U., Kuhn, S., Dufeu, P., Dettling, M., Gräf, K., Rolfs, A., Rommelspacher, H., and Schmidt, L. G. 1996. Lack of allelic association of dopamine D1 and D2 (Taql A) receptor gene polymorphisms with reduced dopaminergic sensitivity in alcoholism. Alcohol. Clin. Exp. Res. 20:1109–1113.
Sander, T., Murat, L., Samochowiec, J., Finckh, U., Romelspacher, H., and Schmidt, L. G. 1999. Lack of an allelic association between polymorphisms of the dopamine D2 receptor gene and alcohol dependence in the German population. Alcohol. Clin. Exp. Res. 23:578–581.
Suarez, B. K., Parsian, A., Hampe, C. L., Todd, R. D., Reich, T., and Cloninger, C. R. 1994. Linkage disequilibria and the D2 dopamine receptor locus (DRD2) in alcoholics and controls. Genomics 19:12–20.
Blum, K., Sheridan, P. J., Wood, R. C., Braverman, E. R., Chen, I. J. H., and Comings, D. E. 1995. Dopamine D2 receptor gene variants: Association and linkage studies in impulsive-addictive-compulsive behavior. Pharmacogenetics 5:121–141.
Cloninger, C. R. 1991. D2 dopamine receptor gene is associated but not linked with alcoholism. JAMA 266:1833–1834.
Cook, C. C. H. and Gurling, H. M. D. 1994. The D2 dopamine receptor gene and alcoholism: A genetic effect on the liability for alcoholism. J. R. Soc. Med. 87:400–402.
Gorwood, P., Ades, J., and Feingold, J. 1994. Are genes coding for dopamine receptors implicated in alcoholism? Eur. Psychiatry 9:63–69.
Noble, E. P. 2000. The DRD2 gene in psychiatric and neurological disorders and its phenotypes. Pharmacogenomics 1:309–333.
Pato, C. N., Macciardi, F., Pato, M. T., Verga, M., and Kennedy, H. 1993. Review of the putative association of dopamine D2 receptor and alcoholism: A meta-analysis. Am. J. Med. Genet. 48:78–82.
Uhl, G., Blum, K., Noble, E., and Smith, S. 1993. Substance abuse vulnerability and D2 receptor gene. Trends Neurosci. 16: 83–88.
Gelernter, J., Goldman, D., and Risch, N. 1993. The A1 allele of the D2 dopamine receptor gene and alcoholism. JAMA 268: 1673–1677.
Noble, E. P. and Blum, K. 1993. Alcoholism and the D2 receptor gene [letter]. JAMA 270:1547.
Smith, S. S., O'Hara, B. F., Persico, A. M., Gorelick, D. A., Newlin, D. B., Vlahov, D., Solomon, L., Pickens, R., and Uhl, G. R. 1992. Genetic vulnerability to drug abuse: The D2 dopamine receptor Taql B1 restriction fragment length polymorphism appears more frequently in polysubstance abusers. Arch. Gen. Psychiatry 49:723–727.
O'Hara, B. F., Smith, S. S., Bird, G., Persico, A. M., Suarez, B. K., Cutting, G. R., and Uhl, G. R. 1993. Dopamine D2 receptor RFLPs, haplotypes and their association with substance use in black and caucasian research volunteers. Hum. Hered. 43: 209–218.
Comings, D. E., Muhleman, D., Ahn, C., Gysin, R., and Flanagan, S. D. 1994. The dopamine D2 receptor gene: A genetic risk factor in substance abuse. Drug Alcohol Depend. 34:175–180.
Noble, E. P., Blum, K., Khalsa, M. E., Ritchie, T., Montgomery, A., Wood, R. D., Fitch, R. J., Ozkaragoz, T., Sheridan, P. J., Anglin, M. D., Parades, A., Treiman, L. J., and Sparkes, R. S. 1993. Allelic association of the D2 dopamine receptor gene with cocaine dependence. Drug Alcohol Depend. 33:271–285.
Persico, A. M., Bird, G., Gabbay, F. H., and Uhl, G. R. 1996. D2 dopamine receptor gene Taql A1 and B1 restriction fragment length polymorphism: Enhanced frequencies in psychostimulant-preferring polysubstance abusers. Biol. Psychiatry 40:776–784.
Noble, E. P., St Jeor, S. T., Ritchie, T., Syndulco, K., St Jeor, S. C., Fitch, R. J., Brunner, R. L., and Sparkes, R. S. 1994. D2 dopamine receptor gene and cigarette smoking: A reward gene? Med. Hypotheses 42:257–260.
Comings, D. E., Ferry, L., Bradshaw-Robinson, S., Burghette, R., Chiu, C., and Muhleman, D. 1996. The dopamine D2 receptor (DRD2) gene: A genetic risk factor in smoking. Pharmacogenetics 6:73–79.
Spitz, M. R., Shi, H., Yang, F., Hudmon, K. S., Jiang, H., Chamberlain, R. M., Amos, C. I., and Wan, Y. 1998. Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. J. Natl. Cancer Inst. 90:358–363.
Lawford, B. R., Young, R. McD., Noble, E. P., Sargent, J., Rowell, J., Shadforth, S., Zhang, X., and Ritchie, T. 2000. The D2 dopamine receptor A1 allele and opioid dependence: Association with heroin use and response to methadone treatment. Am. J. Med. Genet. (Neuropsychiat. Genet.) 96:592–598.
Comings, D. E., Flanagan, S. D., Dietz, G., Muhleman, D., Knell, E., and Gysin, R. 1993. The dopamine D2 receptor (DRD2) as a major gene in obesity and weight. Biochem. Med. Metabol. Biol. 50:176–185.
Noble, E. P., Noble, R. E., Ritchie, T., Syndulko, K., Bohlman, M. C., Noble, L. A., Zhang, Y., Sparkes, R. S., and Grandy, D. K. 1994. Allelic association of the human D2 dopamine receptor gene and obesity. Int. J. Eat. Disord. 15:205–217.
Comings, D. E., Gade, R., MacMurray, J. P., Muhleman, D., and Peters, W. R. 1996. Genetic variants of the human obesity (OB) gene: Association with body mass index in young women, psychiatric symptoms, and interaction with the dopamine D2 receptor (DRD2) gene. Molec. Psychiatry 1:325–335.
Spitz, M. R., Detry, M. A., Pillow, P., Hu, Y. H., Amos, C. I., Hong, W. K., and Wu, X. F. 2000. Variant alleles of the D2 dopamine receptor gene and obesity. Nutri. Res. 20:371–380.
Noble, E. P., Zhang, X., Ritchie, T. L., and Sparkes, R. S. 2000. Haplotypes at the DRD2 locus and severe alcoholism. Am. J. Med. Genet. (Neuropsychiat. Genet.) 96:622–631.
Blum, K., Noble, E. P., Sheridan, P. J., Montgomery, A., Ritchie, T., Ozkaragoz, T., Fitch, R. J., Wood, R., Finley, O., and Sadlack, F. 1993. Genetic predisposition in alcoholism: Association of the D2 dopamine receptor Taql B RFLP in severe alcoholics. Alcohol 10:59-67.
Noble, E. P., Blum, K., Ritchie, T., Montgomery, A., and Sheridan, P. J. 1991. Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch. Gen. Psychiatry 48:648-654.
Thompson, J., Thomas, N., Singleton, A., Piggott, M., Lloyd, S., Perry, E. K., Morris, C. M., Perry, R. H., Ferrier, I. N., and Court, J. A. 1997. D2 dopamine receptor gene (DRD2) Taql A polymorphism: Reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 7:479–484.
Pohjalainen, T., Rinne, J. O., Nåagren, K., Lehikoinen, P., Anttila, K., Syvälahti, E. K. G., and Hietala, J. 1998. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Molec. Psychiatry 3:256–260.
Jönsson, E. G., Nöthen, M. M., Grünhage, F., Farde, L., Nakashima, Y., Propping, P., and Sedvall, G. C. 1999. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Molec. Psychiatry 4:290–296.
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullins, K. B., and Erlich, H. A. 1988. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487–491.
Grandy, D. K., Zhang, Y., and Civelli, O. 1993. PCR detection of the Taql A RFLP at the DRD2 locus. Hum. Mol. Genet. 2: 2197.
Castiglione, C. M., Deinard, A. S., Speed, W. C., Sirugo, G., Rosenbaum, H. C., Zhang, Y., Grandy, D. K., Grigorenko, E. L., Bonne-Tamir, B., Pakstis, A. J., Kidd, J. R., and Kidd, K. K. 1995. Evolution of haplotypes at the DRD2 locus. Am. J. Hum. Genet. 57:1445–1456.
Sarkar, G. and Sommer, S. S. 1991. Haplotyping by double PCR amplification of specific alleles. Biotechniques 10:436–440.
Kidd, K. K., Pakstis, A. J., Castiglione, C. M., Kid, J. R., Speed, W. C., Goldman, D., Knowler, W. C., Lu, R.-B., and Bonne-Tamir, B. 1996. DRD2 haplotypes containing the Taql A1 allele: Implications for alcoholism research. Alcohol. Clin. Exp. Res. 20:697–705.
Arinami, T., Gao, M., Hamaguchi, H., and Toru, M. 1997. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum. Mol. Genetic. 6:577–582.
Samochowiec, J., Ladehoff, M., Pelz, J., Smolka, M., Schmidt, L. G., Rommelspacher, H., and Finckh, U. 2000. Predominant influence of the 3′-region of dopamine D2 receptor gene (DRD2) on the clinical phenotype in German alcoholics. Pharmacogenetics 10:471–475.
Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265–275.
Munson, P. J. and Rodbard, D. 1980. LIGAND: A versatile computerized approach for characterization for ligand-binding systems. Anal. Biochem. 107:220–239.
Weir, B. S. 1996. Genetic data analysis II: Methods for discrete population genetic data. Sinauer Associates, Sunderland, Massachusetts.
Weir, B. S. and Cockerham, C. C. 1989. Complete characterization of disequilibrium at two loci. Pages 86–110, in Feldman, M. E. (ed.), Mathematical Evolutionary Theory, Princeton University Press, New Jersey.
Seeman, P., Ulpian, C., Bergeron, C., Riederer, P., Jellinger, K., Gabriel, E., Reynolds, G. P., and Tourtellotte, W. W. 1984. Bimodal distribution of dopamine receptor densities in brains of schizophrenics. Science 225:728–730.
De Keyser, J., Walraevens, H., De Backer, J.-P., Ebinger, G., and Vauquelin, G. 1989. D2 dopamine receptors in the human brain: Heterogeneity based on differences in guanine nucleotide effect on agonist binding, and their presence on corticostriatal nerve terminals. Brain Res. 484:36–42.
Severson, J. A., Marcusson, J., Winblad, B., and Finch, C. E. 1982. Age-correlated loss of dopaminergic binding sites in human basal ganglia. J. Neurochem. 39:1623–1631.
Laruelle, M., Gelernter, J., and Innis, R. B. 1998. D2 receptors binding potential is not affected by Taql polymorphism at the D2 receptor gene. Mol. Psychiatry 3:261–265.
Hitzemann, R. J. 1998. The regulation of D2 dopamine receptor expression. Mol. Psychiatry 3:198–203.
Silvestri, S., Seeman, M. V., Negrete, J.-C., Houle, S., Shammi, C. M., Remington, G. J., Kupar, S., Zipursky, R. B., Wilson, A. A., Christensen, B. K., and Seeman, P. 2000. Increased dopamine D2 receptor binding after long-term treatment antipsychotics in humans: A clinical PET study. Psychopharmacology 152:174–180.
Pohjalainen, T., Nåagren, K., Syvälahti, E. K., and Hietala, J. 1999. The dopamine D2 receptor 5′-flanking variant,-141C Ins/Del, is not associated with reduced dopamine D2 receptor density in vivo. Pharmacogenetics 9:505–509.
Gelernter, J., Kranzler, H., Cubells, J. F., Ichimose, H., and Nagatsu, T. 1998. DRD2 allele frequencies and linkage disequilibria, including the-141C Ins/Del promoter polymorphism, in European-American, African-American and Japanese subjects. Genomics 51:21–26.
Ishiguro, H., Arinami, T., Saito, T., Akazawa, S., Enomoto, M., Mitushio, H., Fujishiro, H., Tada, K., Akimoto, Y., Mifune, H., Shioduka, S., Hamaguchi, H., Toru, M., and Shibuya, H. 1998. Association study between the-141C Ins/Del and Taql A polymorphisms of the doamine D2 receptor gene and alcoholism. Alcoholism Clin. Exp. Res. 22:845–848.
Parsian, A., Cloninger, C. R., and Zhang, Z. H. 2000. Functional variant in the DRD2 receptor promoter region and subtypes of alcoholism. Am. J. Med. Genet. 96:407–411.
Kidd, K. K., Bharati, M., Castiglione, C. M., Zhao, H., Pakstis, A. J., Speed, W. C., Bonne-Tamir, B., Lu, R.-B., Goldman, D., Lee, C., Nam, Y. S., Grandy, D. K., Jenkins, T., and Kidd, J. R. 1998. A global survey of haplotype frequencies and linkage disequilibrium at the DRD2 locus. Hum. Genet. 103:211–227.
Hietala, J., West, C., Syvälahti, E., Någren, K., Lehikoinen, P., Sonninen, P., and Ruotsalainen, U. 1994. Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence. Psychopharmacology 116:285–290.
Volkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Hitzemann, R., Ding, Y.-S., Pappas, N., Shea, C., and Piscani, K. 1996. Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcohol. Clin. Exp. Res. 20:1594–1598.
Thanos, P. K., Volkow, N. D., Freimuth, P., Umegaki, H., Ikari, H., Roth, G., Ingram, D. K., and Hitzemann, R. 2001. Over-expression of dopamine D2 receptors reduces alcohol self-administration. J. Neurochem. 78:1094–1103.
Noble, E. P. 1996. The gene that rewards alcoholism. Sci. Am. Sci. Med. 3:52–61.
Gandelman, K. Y., Harmon, S., Todd, R. D., and O'Malley, K. L. 1991. Analysis of the structure and expression of the human dopamine D2 A receptor gene. J. Neurochem. 56:1024–1029.
Eubanks, J., Djabali, M., Selleri, L., Grandy, D. K., Civelli, O., McElligott, D. L., and Evans, G. A. 1992. Structure and linkage of the D2 dopamine receptor and neural cell adhesion molecule genes on human chromosome 11q23. Genomics 14:1010–1018.
Carswell, S. and Alwine, J. C. 1989. Efficiency of utilization of the simian virus 40 late polyadenylation site: Effects of upstream sequences. Mol. Cell. Biol. 9:4248–4258.
Rotondaro, L., Mele, A., and Rovera, G. 1996. Efficacy of different viral promoters in directing gene expression in mammalian cells: Effect of 3′-untranslated sequences. Gene 168:195–198.
Mammès, O., Betoulle, D., Aubert, R., Giraud, V., Tuset, S., Petiet, A., Colas-Linhart, N., and Fumeron, F. 1998. Novel polymorphisms in the 5′ region of the LEP gene: Association with leptin levels and response to low-calorie diet in human obesity. Diabetes 47:487–489.
Cooper, D. N. 1992. Regulatory mutations and human genetic disease. Ann. Med. 24:427–437.
Bedell, M. A., Jenkins, N. A., and Copeland, N. G. 1996. Good genes in bad neighbourhoods. Nat. Genet. 12:229–232.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ritchie, T., Noble, E.P. Association of Seven Polymorphisms of the D2 Dopamine Receptor Gene with Brain Receptor-Binding Characteristics. Neurochem Res 28, 73–82 (2003). https://doi.org/10.1023/A:1021648128758
Issue Date:
DOI: https://doi.org/10.1023/A:1021648128758